The changes in tumor markers CEA, Ca 19-9 and Ca 125 in monitoring of response to systemic chemotherapy in elderly patients with advanced gastric cancer;Le modificazioni dei valori dei markers tumorali CEA, Ca 19-9 e Ca 125 nel monitoraggio della risposta alla chemioterapia in pazienti anziani con carcinoma gastrico avanzato

Clinica Terapeutica

Volumn 153, Issue 6, 2002, Pages 373-375

  Caponetti, Rosita ^a,d   Caponetti, T ^b   Vici, P ^c  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d NONE   (Italy)

Author keywords

Ca 125; Ca 19 9; CEA; Gastric cancer; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; TUMOR MARKER;

ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; PATIENT MONITORING; PROGNOSIS; STOMACH CANCER; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MONITORING, PHYSIOLOGIC; PALLIATIVE CARE; PROGNOSIS; STOMACH NEOPLASMS; TIME FACTORS;

EID: 0036877233     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Uemura N, Okamoto S, Yamamoto S, et al.: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 13; 345(11): 784-789, 2001
2. Chung AY, Chow PK, Yu WK, et al.: Prevalence of Helicobacter pylori in gastric cancer in a South-east Asian Population by 14C-Urea breath test. ANZ J Surg 71(10): 574-576, 2001
3. Moshkovitz M, Niv Y: Helicobacter pylori and gastric cancer. Harefuah 140(8): 738-743, 2001
4. Maeda S, Akanuma M, Mitsuno Y, et al.: Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem Nov. 30; 276(48): 44856-44864, 2001
5. Konturek PC, Konturek SJ, Pierzehalski P, et al.: Cancerogenesis in Helicobacter pylori infected stomach-role of growth factor apoptosis and cyclooxygenases. Med Sci Monit 7(5): 1092-1107, 2001
6. Ohkura H, Sugano K: Tumor markers in gastric cancer. Nippon Rinsho 59: 208-12, 2001 (Suppl. 4)
7. Baldus SE, Hanish FG.: Biochemistry and pathological importance of mucin-associated antigen in gastrointestinal neoplasia. Adv Cancer Res 79: 201-248, 2000
8. Kim DY, Kim HR, Shim JH et al.: Significance of serum and tissue carcinoembryonic antigen the prognosis of gastric carcinoma patients. J Surg Oncol 74: 185-192, 2000
9. Abe N, Watanabe T, Toda H, et al.: Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer. Am J Surg 181 (4): 356-361, 2001
10. Ychou M, Duffour J, Kramar A, et al.: Clinical significance and prognostic value of Ca 72-4 compared with CEA and Ca 19-9 in patients with gastric cancer. Dis Markers 16 (3-4): 105-110, 2000
11. Nakata B, Hirakawa-YS, Ching K, Kato Y, et al.: Serum Ca 125 levels as a predictor of pertoneal dissemination in patients with gastric carcinoma. Cancer 83: 2488-2492, 1998
12. Yamao T, Kai S, Kazami A, et al.: Tumor markers CEA, Ca 19-9 and Ca 125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer. Jpn J Clin Oncol 29(11): 550-555, 1999
13. Zinser JW: Tumor markers in cancer of digestive system. Rev Gastroenterol Mex 62(3): 145-148, 1997
14. Webb A, Scott-Mackie P, Cunningham D, et al.: The prognostic value of serum and immunohistochemical tumor markers in advanced gastric cancer. Eur J cancer 32A(1): 63-68, 1996
15. Gaspar MJ, Arribas I, Coca MC, et al.: Prognostic value of carcinoembryonic antigen, Ca 19-9 and Ca 72-4 in gastric carcinoma. Tumour Biol 22(5): 318-322, 2001
16. Beker KF, Keller G, Hoefler H: The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 9(1): 5-11, 2000
17. Nakata B, Chung KH, Muguruma K, et al.: Changes in tumor markers levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma. Cancer 83: 19-24, 1998